My record: ≈400 [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2024-05-03 16:19 (17 d 12:50 ago) – Posting: # 23980
Views: 952

Hi Achievwin,

❝ ❝ BTW, I have seen 4-period full replicate studies with 180 healthy volunteers…

❝ wow for a full replicate N=400 the sponsor has deep pockets…

Nope. ≈400 (parallel), 180 4-period full replicate1 but there are even larger ones (252 subjects started, 238 completers).2 If your drug is a blockbuster1 and you have to change the formulation, you would do it.


  1. U.S. National Library of Medicine [2014-05-19] – Identifier NCT01290757
  2. Davit BM, Patel DT. Bioequivalence of Highly Variable Drugs. In: Yu LX, Li BV, editors. FDA Bioequivalence Standards. New York: aapspress/Springer; 2014. p. 151–2.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,647 registered users;
42 visitors (0 registered, 42 guests [including 7 identified bots]).
Forum time: 05:10 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5